Gilead Sciences, Inc. 13D and 13G filings for Arcus Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-20 7:43 pm Purchase | 2025-02-18 | 13D | Arcus Biosciences, Inc. RCUS | GILEAD SCIENCES INC. GILD | 39,691,649 35.000% | 8,158,868 (+25.87%) | Filing |
| 2024-01-31 4:58 pm Purchase | 2024-01-29 | 13D | Arcus Biosciences, Inc. RCUS | GILEAD SCIENCES INC. GILD | 31,532,781 35.000% | 5,945,828 (+23.24%) | Filing |
| 2023-07-06 09:38 am Purchase | 2023-06-28 | 13D | Arcus Biosciences, Inc. RCUS | GILEAD SCIENCES INC. GILD | 25,586,953 35.000% | 2,863,797 (+12.60%) | Filing |
| 2021-02-02 4:51 pm Sale | 2021-01-31 | 13D | Arcus Biosciences, Inc. RCUS | GILEAD SCIENCES INC. GILD | 22,723,156 35.000% | -6,775,268 (-22.97%) | Filing |
| 2020-07-17 2:01 pm Purchase | 2020-07-08 | 13D | Arcus Biosciences, Inc. RCUS | GILEAD SCIENCES INC. GILD | 29,498,424 35.000% | 29,498,424 (New Position) | Filing |